EMILY SOCORRO: Open Payments
NPI 1932794278 · DORAL, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,144 in 49 payments from 15 companies in 2025. Trend: 2023 $543 · 2024 $802 · 2025 $1,144
Food & beverage: $1,144
| Company | Payments | Amount |
|---|---|---|
| BIOTRONIK INC. | 22 | $547 |
| AstraZeneca Pharmaceuticals LP | 6 | $138 |
| PFIZER INC. | 3 | $67 |
| Amgen Inc. | 3 | $59 |
| SCPHARMACEUTICALS INC. | 2 | $54 |
| Merck Sharp & Dohme LLC | 3 | $49 |
| Novo Nordisk Inc | 2 | $40 |
| BridgeBio Pharma, Inc. | 1 | $34 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $29 |
| Kestra Medical Technology Services, Inc. | 1 | $25 |
Products named: BIOMONITOR, Renamic Neo, VYNDAQEL, REPATHA, FUROSCIX, VERQUVO, Attruby, JARDIANCE.
Industry payments across FL — which companies pay providers there.
